$9.33 -0.48 (-4.89%)
2/10/2012 3:59 PM

Simcere Pharmaceutical Group (NYSE:SCR)

CAPS Rating: 3 out of 5

The Company is a manufacturer and supplier of branded generic pharmaceuticals in the fast growing China market.

Featured Broker Partners


Advertisement